How to Get Fosamax (Alendronate) in Wisconsin

What Is Alendronate (Fosamax) and Why Is It Prescribed?

Alendronate is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption, slowing the breakdown of existing bone mass and reducing fracture risk in patients with osteoporosis or osteopenia. The FDA first approved Fosamax in 1995 for postmenopausal osteoporosis; the label was later extended to cover male osteoporosis and glucocorticoid-induced osteoporosis.

The Fracture Intervention Trial (FIT, JAMA 1998, N=2,027) demonstrated that alendronate 10 mg daily reduced the risk of morphometric vertebral fractures by 47% over three years compared with placebo in postmenopausal women with low bone density [1]. That same trial found a 51% reduction in hip fractures in the subset of women with existing vertebral fractures. These numbers are not abstractions. A hip fracture in a patient over 65 carries a one-year mortality of approximately 20 to 30%, making effective prevention a serious clinical priority [2].

The standard adult dose for postmenopausal or male osteoporosis is 70 mg once weekly taken as a single oral tablet. Patients must take the tablet first thing in the morning with 6 to 8 ounces of plain water, remain upright for at least 30 minutes, and avoid food, other beverages, and medications during that window. Alendronate sodium is also available as a 70 mg effervescent tablet and an oral solution, though the weekly tablet is by far the most commonly prescribed form in Wisconsin community pharmacy practice.

The FDA-approved prescribing information specifies a once-daily 5 mg or 10 mg dose for prevention and treatment respectively, but the once-weekly 70 mg regimen has equivalent efficacy with substantially better tolerability and adherence. A 2000 study published in the journal Bone confirmed non-inferior bone mineral density (BMD) gains between daily and weekly regimens [3].

Who Can Prescribe Alendronate in Wisconsin?

Four clinician categories hold prescriptive authority for alendronate in Wisconsin. Each route to a prescription has distinct documentation expectations.

Medical doctors (MDs) and doctors of osteopathic medicine (DOs) hold full independent prescribing authority in Wisconsin under Wis. Stat. § 448.03. They can initiate alendronate based on clinical judgment, DXA results, or FRAX risk calculation without additional oversight.

Advanced practice registered nurses (APRNs) and nurse practitioners (NPs) in Wisconsin may prescribe independently if they hold a certificate of independent practice issued after at least two years of clinical experience. APRNs without that certificate prescribe under a written collaborative agreement with a supervising physician. Either category is fully authorized to prescribe alendronate.

Physician assistants (PAs) prescribe under a supervision agreement with a collaborating physician as required by Wis. Stat. § 448.9785. PAs in internal medicine, endocrinology, rheumatology, and primary care routinely manage osteoporosis and prescribe bisphosphonates.

Telehealth clinicians licensed in Wisconsin follow the same prescribing rules regardless of physical location. Wisconsin adopted the Interstate Medical Licensure Compact, so a clinician licensed in another compact state who also holds a Wisconsin license may write a valid Wisconsin prescription via a synchronous telehealth visit.

How to Get a Fosamax Prescription in Wisconsin: Step by Step

Getting alendronate in Wisconsin follows a predictable sequence. Short steps can move fast. Here is the full path from first contact to first tablet.

Step 1. Gather your bone density records. A DXA scan result is not legally required before a clinician writes an alendronate prescription, but most Wisconsin prescribers and all Wisconsin Medicaid prior authorization forms require objective evidence of low bone mass (T-score of -2.5 or below for osteoporosis, or -1.0 to -2.4 for osteopenia with elevated FRAX risk). If you do not have a recent DXA, schedule one. Wisconsin has DXA imaging available at most major hospital systems, including UW Health, Froedtert, Aurora, Bellin, and Aspirus.

Step 2. Complete baseline laboratory work. Before initiating alendronate, your clinician will generally order serum calcium, 25-hydroxyvitamin D, creatinine (to confirm adequate kidney function, since alendronate is contraindicated when creatinine clearance falls below 35 mL/min), and a basic metabolic panel. Hypocalcemia must be corrected before starting therapy because bisphosphonates can worsen low calcium levels.

Step 3. Attend a clinical visit, in person or via telehealth. Wisconsin explicitly permits telehealth prescribing under Wis. Stat. § 448.9785 and the Wisconsin Telehealth Act of 2015. A synchronous audio-video visit with a Wisconsin-licensed clinician is sufficient to initiate a new prescription for alendronate when the clinician has reviewed your DXA results and lab work. The visit typically lasts 20 to 30 minutes. Several national telehealth platforms hold Wisconsin licenses, and HealthRX operates within Wisconsin's telehealth framework for bone-health consultations.

Step 4. Send your prescription to a Wisconsin pharmacy or mail-order pharmacy. Electronic prescriptions (e-prescriptions) are the standard in Wisconsin. Your clinician sends the order directly to your pharmacy's system. For a 70 mg once-weekly prescription, you receive four tablets per 28-day supply. Most major Wisconsin pharmacy chains, including Walgreens, CVS, Walmart Pharmacy, and independent regional pharmacies, stock generic alendronate sodium 70 mg tablets.

Step 5. Pick up or receive your medication. In-store pickup is usually same day or next day after e-prescription transmission. Mail-order through Wisconsin-based or national pharmacy benefit managers (PBMs) typically takes two to five business days. If your insurance uses a mail-order mandate for maintenance medications, the first fill may require a manual override for an in-store 30-day supply.

The HealthRX clinical team uses a four-checkpoint framework before finalizing an alendronate prescription for Wisconsin patients: (1) confirmed low bone mass via DXA T-score or FRAX 10-year major osteoporotic fracture probability above 20%, (2) adequate renal function with creatinine clearance at or above 35 mL/min, (3) corrected or normal serum calcium with supplemental calcium and vitamin D prescribed if needed, and (4) documentation of the ability to remain upright for 30 minutes post-dose. All four checkpoints must be satisfied before the e-prescription is transmitted.

Telehealth Prescribing for Fosamax in Wisconsin

Wisconsin's telehealth legal framework is one of the more permissive in the Midwest. A clinician does not need to have seen a patient in person previously to prescribe alendronate via telehealth, provided the video visit constitutes a valid patient-clinician relationship under Wisconsin administrative code and the clinician reviews sufficient clinical data (DXA result, labs, medication list) to make a safe prescribing decision.

The Ryan Haight Online Pharmacy Consumer Protection Act applies to Schedule II through V controlled substances. Alendronate is not a controlled substance, so Ryan Haight restrictions do not apply. A Wisconsin-licensed clinician can prescribe alendronate after a compliant telehealth visit without any additional federal hurdles.

Several telehealth workflows specifically serve Wisconsin patients for bone health. Some endocrinology and internal medicine practices at UW Health and Froedtert offer MyChart video visits for osteoporosis management. Direct-to-patient telehealth platforms that hold Wisconsin clinician licenses can initiate and manage alendronate therapy entirely remotely. A 2022 analysis published in the Journal of Bone and Mineral Research found that telehealth-initiated osteoporosis treatment achieved comparable medication adherence at 12 months relative to in-person initiation, with 67% adherence in the telehealth cohort vs. 64% in the clinic cohort [4].

Dr. Carolyn Crandall, Professor of Medicine at UCLA and a co-author of the American College of Physicians 2017 osteoporosis clinical practice guidelines, stated in those guidelines: "Clinicians should offer pharmacological treatment with alendronate, risedronate, zoledronic acid, or denosumab to reduce the risk of hip and vertebral fractures in women who have known osteoporosis." [5] That recommendation applies regardless of whether the prescription originates from a physical clinic or a telehealth visit.

Wisconsin Insurance Coverage and Prior Authorization

Generic alendronate 70 mg is on Tier 1 (preferred generic) of most Wisconsin commercial insurance formularies, which generally means a copay of $0 to $10 per month. Brand Fosamax is rarely covered because generic alendronate sodium is bioequivalent and far less expensive.

Wisconsin Medicaid (ForwardHealth) covers alendronate for the treatment of osteoporosis with prior authorization. The ForwardHealth Preferred Drug List requires PA for bisphosphonates when prescribed for osteoporosis. The PA criteria, as of 2024, require:

1. A documented diagnosis of osteoporosis (ICD-10 M81.x) or osteopenia with high fracture risk.
2. A DXA T-score result on file, or clinical documentation of fragility fracture history.
3. Confirmation that the patient has no contraindications (renal insufficiency with CrCl <35 mL/min, hypocalcemia, esophageal abnormalities).
4. Prescriber attestation that vitamin D and calcium supplementation have been addressed.

PA approval for alendronate under ForwardHealth typically takes two to five business days. Urgent PA is available for patients with recent fragility fractures. Wisconsin Medicaid members can receive the medication through any Wisconsin-enrolled pharmacy once PA is approved.

Medicare Part D covers generic alendronate on most Wisconsin Part D plan formularies at the Tier 1 or Tier 2 level. The 2024 Medicare Part D out-of-pocket cap of $3 to 300 in the initial coverage phase rarely affects alendronate patients because annual alendronate costs are well below that threshold at generic pricing.

GoodRx and cash pay. Patients without insurance or with high-deductible plans can obtain generic alendronate 70 mg (4 tablets, one-month supply) for $4 to $12 at Wisconsin Walmart Pharmacy, Costco Pharmacy, and many independent pharmacies using GoodRx or similar discount programs.

Lab Work Required Before Starting Alendronate in Wisconsin

Labs are not optional clinical formalities. Alendronate can precipitate severe hypocalcemia in patients with vitamin D deficiency, and the drug is renally cleared in a way that creates toxicity risk in significant kidney disease. Wisconsin clinicians, whether in-person or telehealth-based, will generally require the following before writing the first prescription.

Serum calcium. Must be within the normal range (typically 8.5 to 10.2 mg/dL) before initiation. Hypocalcemia is a labeled contraindication per the FDA prescribing information for alendronate sodium [6].

25-hydroxyvitamin D. A level below 20 ng/mL (50 nmol/L) requires supplementation before or alongside alendronate initiation. The Endocrine Society recommends 1,500 to 2 to 000 IU of vitamin D3 daily for adults at risk of deficiency. Alendronate does not substitute for vitamin D; the two work through separate mechanisms and both are needed for the drug to function safely [7].

Serum creatinine and estimated GFR (eGFR). The FDA label contraindicates alendronate when creatinine clearance falls below 35 mL/min. Patients with chronic kidney disease stages 3b and above require nephrology input before bisphosphonate therapy.

Basic metabolic panel (BMP). Provides creatinine, potassium, and bicarbonate data, all relevant to identifying conditions that interact with alendronate's GI and renal profile.

DXA scan. Not a blood test, but the central imaging study for this drug class. A dual-energy X-ray absorptiometry scan of the hip and lumbar spine produces T-scores. The World Health Organization defines osteoporosis as a T-score of -2.5 or below at any measured site; osteopenia falls between -1.0 and -2.4 [8]. Most Wisconsin Medicaid PA requests and commercial prior authorization requests will not be approved without a DXA result in the past two years.

Transferring a Fosamax Prescription to Wisconsin

Patients moving to Wisconsin or switching from an out-of-state provider to a Wisconsin clinician can transfer their existing alendronate prescription as long as the original prescription still has refills remaining. Wisconsin pharmacy law permits prescription transfers between pharmacies (including interstate transfers) for non-controlled substances. You call or visit your new Wisconsin pharmacy, provide the original pharmacy's name and phone number, and the pharmacy contacts it directly.

If refills are exhausted or the original prescription is more than one year old, a new prescription from a Wisconsin-licensed clinician is required. A telehealth visit with a Wisconsin-licensed provider can accomplish this quickly, typically within 24 to 48 hours of scheduling the visit, including DXA and lab review.

Important note on compounded alendronate. A small number of patients who cannot tolerate oral alendronate tablets (due to esophageal disease or severe GI intolerance) may be candidates for a compounded alendronate preparation. Wisconsin has licensed 503A compounding pharmacies. A 503A pharmacy may compound alendronate into an alternative delivery form for an individual patient based on a valid prescription from a Wisconsin-licensed prescriber. This is a narrow use case; the vast majority of patients tolerate the standard oral tablet without issue.

Monitoring and Follow-Up After Starting Alendronate in Wisconsin

Starting alendronate is not a one-time event. The American Association of Clinical Endocrinologists (AACE) 2020 clinical practice guidelines for osteoporosis specify that patients on bisphosphonate therapy should have a follow-up DXA scan at two to three years to assess treatment response [9].

Serum calcium and vitamin D should be rechecked at approximately three to six months after initiation, particularly in patients who were borderline deficient at baseline. The treating clinician should review the patient's GI tolerability at each visit. Esophageal irritation is the most common side effect of alendronate, occurring in up to 10 to 15% of patients in early clinical trials, and is almost always preventable by strict adherence to the dosing instructions (full glass of water, remaining upright for 30 minutes).

After five to ten years of continuous bisphosphonate therapy, clinicians should assess whether a drug holiday is appropriate. The FLEX extension trial (N=1,099) found that fracture risk in lower-risk patients did not increase significantly after discontinuing alendronate at five years, while high-risk patients (T-score at or below -2.5 at the femoral neck after five years of treatment) benefited from continued therapy [10]. A Wisconsin clinician or telehealth provider should conduct this reassessment before year five of treatment.

Wisconsin residents without a current osteoporosis specialist can access endocrinology telehealth through UW Health Virtual Care, Froedtert TeleHealth, or a national telehealth platform holding Wisconsin licensure. Follow-up DXA scheduling can be placed through any Wisconsin radiology group that accepts the patient's insurance.

503A Compounding Pharmacies in Wisconsin and Alendronate

Standard oral alendronate sodium 70 mg tablets are manufactured generically by multiple FDA-approved manufacturers and are widely available. Compounding is rarely indicated. But for patients with documented intolerance to the standard tablet form, Wisconsin 503A pharmacies can legally compound alendronate under a valid patient-specific prescription.

A 503A pharmacy is a state-licensed compounding pharmacy that compounds medications for individual patients, as opposed to 503B outsourcing facilities that produce larger batches. Wisconsin's Department of Safety and Professional Services (DSPS) licenses and oversees 503A pharmacies. Compounded alendronate preparations are not FDA-approved products, meaning the compounded version has not undergone the same bioavailability and stability testing as the commercial tablet. Prescribers and patients should reserve compounded forms for situations where the standard product is genuinely unavailable or medically inappropriate.